ALEXION PHARMACEUTICALS INC
- Blueprint Cuts $265M Alexion Deal With IPO in Sight Xconomy Venture Capital Feed
- Alexion Appoints New Chief Executive Officer Pharmpro News
- HealthInvest raising $75 million The Greenwich Time - Business - Greenwich, CT
- Alexion Pharmaceuticals co-founder Stephen Squinto to retire Jan. 1 The Franklin Daily Journal - Business
- Alexion Names New Chairman After Death Of Founding Board Member The Hartford Courant - Business - Hartford, CT
- Alexion Pharmaceuticals Inc. Announces The Appointments Of And To Its Board Of Directors Bio Space - Breaking News
- Alexion recalls Soliris for third time for particulate Fierce Pharma Manufacturing
- On a roll in Ireland, Alexion plots 200-job supply chain hub Fierce Pharma
- Prothelia and Alexion partner with University of Nevada for ultra-rare neuromuscular disorder The Pharma Letter - All news and articles
- Alexion, Moderna ink rare diseases agreement Clinical Trials Today [CenterWatch]
Community Payment Ratings
Cortera is much more than an awesome business directory! It's an active community where real business people share the real deal on real businesses.
It's invaluable intel that's now available for FREE.
- Get the inside scoop with ratings and reviews on ALEXION PHARMACEUTICALS INC
- Rate ALEXION PHARMACEUTICALS INC on their payment behavior
- Ask your network about ALEXION PHARMACEUTICALS INC with Cortera Circles
The information contained in this company profile is compiled from third party sources, including but not limited to public records, user submissions, and other commercially available data sources. These sources may not be accurate, complete, or up-to-date. Cortera makes no representations or warranties regarding, and assumes no responsibility for, the accuracy, completeness, or currency of the information contained herein.